Weight Loss Drug Market Looks to Expand, While EMA Expands Review of GLP-1 Agonists and Suicide

In an expansion of its investigation into suicidal ideation associated with GLP-1 agonists, the European Medicines Agency (EMA) wants manufacturers to answer some undisclosed questions about these drugs, while the popularity of these drugs also continues to expand.
Source: Drug Industry Daily